Hit to lead optimization of isopentenyl chalcones as novel MTHFD2 inhibitors for cancer treatment: design, synthesis, in-vitro, in-vivo and in-silico studies
Yingjie Hu, Xiangli He, Shuhui Li, Tingting Zhang, Jingjing Liao, Ning Xu, Yaxia Yuan, Qi Wang, Zhuo Chen, Jin Huang, Lei Ma